Abstract
Free full text
Lack of p21 expression links cell cycle control and appendage regeneration in mice
Abstract
Animals capable of regenerating multiple tissue types, organs, and appendages after injury are common yet sporadic and include some sponge, hydra, planarian, and salamander (i.e., newt and axolotl) species, but notably such regenerative capacity is rare in mammals. The adult MRL mouse strain is a rare exception to the rule that mammals do not regenerate appendage tissue. Certain commonalities, such as blastema formation and basement membrane breakdown at the wound site, suggest that MRL mice may share other features with classical regenerators. As reported here, MRL fibroblast-like cells have a distinct cell-cycle (G2/M accumulation) phenotype and a heightened basal and wound site DNA damage/repair response that is also common to classical regenerators and mammalian embryonic stem cells. Additionally, a neutral and alkaline comet assay displayed a persistent level of intrinsic DNA damage in cells derived from the MRL mouse. Similar to mouse ES cells, the p53-target p21 was not expressed in MRL ear fibroblasts. Because the p53/p21 axis plays a central role in the DNA damage response and cell cycle control, we directly tested the hypothesis that p21 down-regulation could functionally induce a regenerative response in an appendage of an otherwise nonregenerating mouse strain. Using the ear hole closure phenotype, a genetically mapped and reliable quantitative indicator of regeneration in the MRL mouse, we show that the unrelated Cdkn1atmi/Tyj/J p21−/− mouse (unlike the B6129SF2/J WT control) closes ear holes similar to MRL mice, providing a firm link between cell cycle checkpoint control and tissue regeneration.
The ability to regenerate appendages is generally considered to be a property of organisms other than mammals, which typically heal wounds by the process of repair characterized by wound site contraction and closure with a scar. On the other hand, the replacement of limbs in the adult newt and the axolotl, for example, after injury or amputation begins with the formation of a blastema, a structure with highly proliferative cells that grows until that appendage is replaced without scarring (1, 2). The ability of blastemal cells in the adult to proliferate until normal architecture with appropriate differentiation into multiple cell types is achieved is a defining feature of regeneration.
The MRL mouse and its close relatives (“healer” strains) have unique healing and regenerative capabilities, including the complete closure and tissue regeneration of through-and-through ear hole puncture wounds with the formation of a circular blastema (3), the regrowth of articular cartilage (4), and the partial regeneration of amputated digits (5, 6).
Genetic mapping of the healing trait using microsatellite and SNP mapping indicates that the MRL healing phenotype is distributed among over 20 loci on multiple chromosomes (7–11). At the current time, the delineation of such a complex phenotype remains elusive. We thus searched for mechanisms and insights by considering previously observed but disparate findings among classical regenerating species such sponges, hydra, planaria, and newt and in cases of limited regeneration (i.e., liver) in mammals.
Sponges and hydra are classic model species used in the study of wound healing, regeneration, allograft rejection, and innate immunity (12). These organisms belong to two of the oldest metazoan lineages in the fossil record and provide molecular and cellular insight into the first evolutionary strategies used by multicellular animals to repair tissue injury and respond to microbial infection. In the case of sponges, the ability to heal injuries and regenerate lost tissue, and the ability to recognize and reject foreign tissue are both associated with the activation of a DNA damage response characterized by increased single-strand scission and the appearance of ribosubstitution and other alkali-labile sites in DNA (13).
In hydra, cells undergo programmed developmental replacement leading to an apparent indefinite lifespan (14). Hydra have a large number of regenerative cells such as interstitial gland cells (15), epithelial cells (16, 17), and cells in the foot (18), which have been shown to exhibit a unique cell-cycle phenotype characterized by G2/M bias. Adult urodele amphibians (e.g., the newt), which can regenerate many of their tissues, initiate cell cycle reentry, local dedifferentiation, and proliferation (2). Interestingly, in culture, myotubes derived from the newt showed serum stimulation driving the myotubes into S phase and arrest in G2 (19). In the regenerative mammalian liver, G2 arrest is a dominant feature in adult hepatocytes, where up to 70% are tetraploid (20). Finally stem cells also show a preference for G2/M arrest (21–23).
We thus initially focused our attention on cell cycle variation as a possible commonality and predictor of regenerative capacity. If this were the case, then we would expect that the MRL mouse would display an uncommon profile of cell cycle variation. Furthermore, we would expect the same of congenic strains in which the MRL healing phenotype is bred into a nonhealing strain, and we would expect the same of the major ancestral mouse strain of the MRL, the LG mouse, which displays the regenerating phenotype as well.
Finally, even if the above hypothesis is correct, it is not at all obvious whether cell cycle variation would be displayed only after injury is initiated and the regenerative response begun or whether these differences would exist in the basal, uninjured state as seen in the hydra.
In the present study, fibroblasts obtained from multiple regenerating (healer) and nonregenerating (nonhealer) mouse strains, recombinant inbred (RI) lines (24), and congenic mice, were examined for their cell cycling properties. It was noted that distinct differences were found between healers and nonhealers in the fraction of cells in G2/M. Further analysis showed a DNA damage response with increased levels of phosphorylated H2AX, an indicator of DNA double strand breaks (DSB) and p53 responses. Direct analysis of DNA damage using comet analysis showed damage in most of the healer cells.
Given the level of endogenous DNA damage and a G2 accumulation of cells in culture, we explored the possibility of a G1 cell cycle checkpoint deficiency. A member of the pathway that maintains a strong G1 checkpoint is the p53-dependent p21 cyclin dependent kinase inhibitor protein. An analysis of p21 expression showed reduced levels in healer cells. To examine the effect of p21 deficiency in tissue regeneration, ear hole closure was tested in a p21-deficient mouse. The results showed that such mice responded like MRL “healer” mice with complete ear hole closure, leading to the conclusion that a G1 checkpoint defect is associated with tissue regeneration in mice.
Results
G2/M Accumulation in Cells from Healer Mice.
Because models of tissue regeneration have implicated cell cycle control mechanisms as a potential common feature among cells capable of tissue regeneration, we examined the cell cycle profile of cells cultured from normal uninjured ear tissue derived from adult healer mice. For this purpose, we used healer MRL and LG/J mice, a congenic line selected for healing (Fig. S1), healer and nonhealer recombinant inbred (RI) lines generated from LG/J healer and SM/J nonhealer mice (24), and nonhealer B6 and SM/J mice. MRL shares 75% of its genome with LG/J, having been produced by two final backcrosses to LG/J (25). We analyzed the cell cycle profile from the in vitro cultured cells of MRL healer and related strains to determine whether the profiles were different from control nonhealer mice. Using standard propidium iodide DNA content labeling and flow cytometry analysis, cell cycle profiles were compared, and the healer cells showed a definitive accumulation in the G2/M phase versus control cells (Fig. 1). Four different pairs of cells were used and all showed a similar accumulation (Table S1). The most dramatic differences were observed when the RI healer and nonhealer strains and the congenic and B6 strains were compared. In the nonhealers, the profile was consistent with what is generally observed in a normal mouse cell population in that the majority of cells were in G1 phase, with smaller percentages seen in S-phase and G2/M. In contrast, the healer cells and in particular the RI line 6 showed 21.5% of cells in G0/G1, whereas 64.1% of cells were in G2/M phase. The pronounced accumulation of cells in G2/M was consistent with that observed in other models of regeneration suggesting that cell cycle control mechanisms are associated with cellular regenerative potential.
Expression and Stabilization of p53 in MRL Healer Cells in Vitro and in Vivo.
The G2/M transition is regulated by a complex series of molecular interactions that can elicit a cell cycle checkpoint that may involve the tumor suppressor p53 protein. To determine if p53 was involved, two different methods were used to assess p53 expression levels (Fig. 2). First, in vitro experiments were carried out with MRL and congenic cells derived from normal uninjured ear tissue compared to nonhealer B6 cells for steady state levels of p53 protein. MRL and healer congenic cells had readily detectable levels of p53, although little or no p53 was detected in B6 (Figs. 2 A and B). By FACS analysis, we also found that most of the p53-positive cells were in the G2/M stage of the cell cycle (Fig. 2C).
Second, healer and nonhealer tissues were examined. Histological sections from normal uninjured MRL and B6 ear tissue and small intestine were processed for immunohistochemistry (IHC). p53 expression is seen in normal MRL tissue (Figs. 2 E, G, I, and K) but is lower or not detectable in B6 tissue (Figs. 2 D, F, H, and J). This is supported by Western analysis of normal ear tissue (Fig. 2L).
To further explore the role of p53 during the regenerative process in vivo, ear hole closure assays were performed on B6 and MRL mice. Extracts from healing ear tissue on day 0, 5, and 10 postinjury were monitored for p53 expression using Western blotting (Fig. 2M). p53 protein levels were increased before and during healing in tissue from MRL compared to B6, showing that this increase in expression accompanies the healer phenotype. These data suggest that a cell cycle checkpoint response may be active at steady state and during healing.
Spontaneous DNA Damage Foci in MRL Healer Mice in Vitro and in Vivo.
The DNA damage response cascade is enacted by two large kinases, ATM and ATR, which respond to various cellular stresses. An early hallmark of an active DNA damage response is the phosphorylation of the variant histone H2AX on the serine 139 residue or (γH2AX) (26). Using immunofluorescence, in vitro cultured MRL and congenic cells derived from normal uninjured ear tissue showed greater numbers of γH2AX foci than control B6 cells (Fig. 3A, white bars) including higher numbers of foci-positive cells and higher numbers of foci per cell. As a control, γ-irradiated (1 Gy, Fig. 3A, black bars) cells showed increased γH2AX foci after irradiation.
Tissue from uninjured ear and small intestine was also examined by IHC (Fig. 3B). MRL tissue displayed a greater level of γH2AX staining compared to B6 tissue. Protein extracts from cultured ear cells and chromatin-enriched ear tissue also demonstrated high levels of γH2AX levels by Western blot analysis (Fig. 3C), reaffirming an active DNA damage response in MRL and congenic normal uninjured cells, both in vitro and in vivo.
The histone protein H2AX can be phosphorylated proximal to DNA DSB after exposure to clastogenic agents, such as ionizing radiation, but also after replication-associated DSB that occur when gaps or single stranded regions are present in front of an advancing replication fork. The DNA damage response pathway that generally governs and protects against so-called replication stress is maintained by the ATR kinase. This kinase is activated by the TopBP1 protein (27). We analyzed the normal uninjured ear-derived cells for increased TopBP1 foci by IHC to further determine an association with an active replication stress response. Like γH2AX, TopBP1 foci were markedly enriched in the healer cells, indicative of an active and constitutive DNA damage checkpoint (Fig. 3D).
Cells from Healer Mice Display Elevated Levels of Endogenous DNA Damage.
Numerous cellular stresses converge upon p53 activation and DNA damage response pathways. To test for bona fide DNA damage, we performed a comet assay at both neutral conditions (detecting DSB alone) and alkaline conditions [detecting both single strand breaks (SSB) and DSB]. The alkaline comet results showed high numbers of comets from MRL and other healer cells derived from normal uninjured ear tissue (an average of 80% comet positive) with large tail moments (Fig. 4A and Table S2). This is in contrast to few or no comets in nonhealer cells. These results agree with the γH2AX foci findings. The neutral comet assay (DSB only) counts were lower than the alkaline (DSB and SSB) counts but still averaged 35% comet-positive cells in the healers.
Increased Rad51 Foci in Healer Cells.
Cells involved in regeneration of tissue should be proliferation-competent and the endogenous DNA damage observed must be repaired. There are two major pathways responsible for DNA DSB repair. Nonhomologous end joining can occur throughout the cell cycle but may be error prone. Homologous recombination, although, is error free and uses a sister chromatid as a template for repair during late S or G2 phases of the cell cycle. Because we observed a G2/M accumulation of MRL cells, we tested whether homologous recombination pathways were up-regulated to repair the endogenous damage. We found Rad51 foci increased in 10–15% of in vitro cultured healer cells compared to 1–2% nonhealer cells (Fig. 4B).
Healer Cells in Vivo Have Increased Markers of Apoptosis.
Although many of the healer cells are repairing the intrinsic DNA damage, others clearly have a different outcome. To examine apoptosis, we examined caspase 3 and TUNEL. MRL tissue showed increased caspase 3 by Western blotting using extracts from small intestine and IHC staining of uninjured ear tissue (Fig. 4C). An increase in TUNEL-positive cells in MRL small intestine was also seen (Fig. 4D). Although the regeneration process requires cell proliferation, it appears to come at a cost to many cells in the population as markers of apoptosis were distinctly increased in healer cells.
Lack of p21 Expression/Induction in Healer Cells in Vitro.
The pronounced intrinsic DNA damage in healer cells was strikingly consistent with recent reports showing that mouse embryonic stem cells display endogenous DNA damage and a faulty G1 checkpoint (23, 28). In those reports, a lack of checkpoint control was attributed in part to a lack of p21 induction. We therefore tested the hypothesis that the MRL healer cells also did not induce the p21 checkpoint protein. In comparison with both a human cell line (HCT116) and a mouse nonhealer cell line (B6), MRL cells did not display p21 protein expression and, furthermore, expression was not induced after DNA damage following ionizing radiation (Fig. 4E).
Deletion of p21 Converts a Nonhealer into a Regeneration-Competent Healer Mouse.
Because p21 was down-regulated in healer cells, we asked whether the deletion of p21 would permit appendage regeneration potential in vivo in a nonregenerating mouse. We examined CDKN1A (p21)−/− mice (29) for ear hole closure over a one month period. The background control strain B6129SF2/J mice were ear punched in parallel and the data compared to MRL and B6 ear hole closure. As seen in Fig. 5A, ear hole closure in 6- to 7-wk-old p21−/− mice was almost identical to that seen in MRL healer mice, healing only slightly less well than MRLs on day 28. Age-matched p21+/+ controls did not close and were similar to B6 nonhealer mice. Gross and histological analysis of the p21−/− ear holes over time showed closing holes with normal dermis, epidermis, and cartilage interspersed with thickened areas of dermis (Fig. 5 B–H). To further establish the link between G1 checkpoint control and the regeneration phenotype, cells derived from the ear pinnae of normal uninjured p21+/+ and p21−/− mice were examined for DNA damage and cell cycle arrest. γH2AX staining (Fig. 5 I, J, and M), comet formation (Fig. 5 K, L, M), and increased levels of cells in G2/M (Fig. 5N) were found in the p21−/− mice compared to the p21+/+ mice. This directly correlated with what was seen in the healer MRL, congenic, and RI mouse cells described above in vivo and in vitro, solidifying the role of p21 underexpression and tissue and appendage regeneration.
Discussion
Many mammals, including humans and most mouse strains, are capable of tissue regeneration to varying degrees. This ranges from the replacement of extensively resected liver lobes to the interstitial replacement of damaged skeletal muscle cells, epithelium, the gut lining, and a modest life-long replacement of CNS neurons and cardiomyocytes. In contrast, with few exceptions (ear hole closure in rabbits and seasonal antler replacement), the regeneration of lost appendage tissue is virtually never seen. The key observation of this paper is that the MRL mouse strain (and close relatives), unique among mice in their ability to close ear holes, shows high levels of DNA damage, a G2/M bias, and a lack of p21 protein expression in both uninjured steady state tissue and postinjury. The functional role of p21 has been demonstrated in a p21 knockout mouse, which displays the same range of cellular effects as seen in the MRL mouse and reproduces appendage regeneration in vivo.
Association of Healing, G2/M Arrest, and DNA Damage.
These studies explore the autoimmune-prone MRL mouse (25), which has unusual healing and regenerative responses after wounding. We have shown here that dermal cells derived from ear pinnae of normal uninjured but regeneration-competent mice show a cell cycle response in culture in which elevated numbers of cells are found in G2/M. This is accompanied by various markers of DNA damage and repair responses including the direct detection of single and double strand DNA breaks (comet assay), an increase in phosphorylated H2AX, TopBP1, Rad51 foci formation, and elevated p53. The comet assay results confirm DNA damage response molecular markers and also show a massive accumulation of DNA SSB and DSB in healer cells. This is in contrast to the cell cycle response of cells from nonregenerating mice including cells from B6, SM/J, and (LG/J × SM/J) recombinant inbred nonhealing mice, which show the majority of cells in G0/G1 and without a constitutively active DNA damage/repair response and DNA damage.
G2/M Arrest in Regenerating Models.
The preponderance of healer cells in G2/M has several parallels in other animals and mammalian tissues capable of regeneration. Hydra, a classic regenerator, has been shown to have a large number of cells in G2/M, especially those in the most regenerative part of the organism (15–18), and estimated to be about 68% of all cells (15). Because terminal differentiation of cells in the hydra can occur from G2, this arrested state is functional (16). A similar result has been reported in planaria (30) and in adult urodele amphibians (e.g., the newt) that can regenerate limbs. In vitro experiments using newt cells show cell cycle reentry, local dedifferentiation, and proliferation (2, 19). Newts have also been shown to have many cells in G2 (31). Most recently, a proteomics study in regenerating axolotl limbs also suggests potential G2 arrest (32). Thus, G2/M arrest appears to be a common finding in regenerating organisms.
In the regenerating mammalian liver, polyploidy is a dominant feature in adult hepatocytes, where up to 70% are tetraploid (33). These cells can be binuclear or mononuclear (34). Also, G2/M arrest is seen in stem cells (21). Why there is a predominance of cells in G2 in tissue capable of a regenerative response is unclear. However, there is evidence that senescent cells [i.e., cells that display similar characteristics of G2/M arrest and a DNA damage response in vitro and in vivo (35, 36)] make proinflammatory cytokines and proteases that may lead to a microenvironment that is positive for cell growth (37, 38). Cells in G2/M could provide a milieu that would enhance a proliferative response once initiated, a response important in self-renewal and regeneration.
DNA Damage Responses, Hyperproliferation, and Apoptosis.
Why is there activation of a DNA damage response in normal tissues of the MRL mouse and related healing strains? MRL mice have been reported to have a mutation in exoI, which is involved in mismatch repair of DNA replication (39). Hence, the exoI mutation may contribute to an accumulation of DNA damage and to G2/M arrest, but it remains unclear how this promotes organ regeneration. Some insight is suggested by a mouse model in which the catalytic subunit of telomerase is deleted. This mouse displays organ failure and defects in maintenance of cell proliferation but can be rescued by an exoI deficiency leading to prolonged lifespan, suggesting a role for exoI mutations in the cellular regeneration phenotype (40).
It is generally thought that certain areas of the genome are especially prone to difficulties in DNA replication and that this stress can trigger the activation of the DNA damage response. It has been reported that constitutive DNA damage and DNA damage responses occur in hyperplastic cells in precancerous tissues (41). Thus, our data suggest that highly regenerative cells resemble the hyperproliferative cells seen in early stages of carcinogenesis. We also observed an increase in cellular apoptosis in regenerative cells. The combined effects of increased proliferation and apoptosis may allow the organism to eliminate old cells and keep the cell turnover rate high as seen, for example, during development in the brain and thymus. Similar increases in apoptosis occur in planaria, Xenopus, and in newt during regenerative responses (42–44).
The intrinsic DNA damage and subsequent G2/M arrest displayed here also activates the homologous recombination pathway, biasing DNA repair pathways toward an error-free mechanism of repair that may be important in maintaining genome stability of newly formed tissues and cells. In support of this idea is the fact that elevated levels of homologous recombination are also seen in the regeneration of rat liver tissue (45).
The lack of p21 expression displayed in our system may be analogous to a diminished checkpoint response necessary for enhanced induced pluripotential stem (iPS) cell formation. A recent report showed that a p53/p21 DNA damage response leading to G1 arrest suppresses iPS formation and that a distinct gene expression profile is required for a stem cell state (46). Tissue regeneration in mice is likely mediated by a stem cell-like phenotype. The same may be true for the MRL mouse, as a distinct G2/M genetic program may need to be initiated for tissue regeneration. In fact, cells positive for Nanog and Sox2 are increased in MRL mouse tissue (47). Although some level of DNA damage can be tolerated during cellular reprogramming, apoptosis can ensue if the levels are too high (48). In the MRL system, persistent DNA damage does occur, leading to apoptosis in a subset of the MRL cell population.
Central Role for p21.
All of the effects observed in this study can be explained by the lack of p21 induction in healer cells. This observation may have numerous consequences that lead to the regeneration phenotype. First, without the p21 protein, a G1 checkpoint cannot be fully enacted, leading to a dependency on the G2 checkpoint and explains the remarkable cell cycle profiles of healer cells. Second, without p21, unscheduled entry into S-phase occurs and enhanced proliferation is seen. In fact, in a recent study examining p21 deletion in human fibroblasts, up-regulation of p53 with enhanced proliferation and replication stress is observed similar to the results seen in our regeneration phenotype (49). Third, increased DNA damage is reported in cells lacking p21 and is probably due to proliferative and replicative stress (49). The inability to enter quiescence at G0 in response to stress leads to G2 arrest, which is also observed in MRL mice.
Other studies have also provided evidence that cell cycle control is important for the regeneration phenotype. In vitro regenerative potential is associated with hyperphosphorylation of Rb in newt myotube cultures (19) and in Rb−/− mouse myotubes (50). These two cases would be functionally similar to the absence of p21, where cyclin-cdk interactions would not be inhibited and would thus bypass the G1 checkpoint. In vivo, the absence of p21 has been shown in double mutant mice to both enhance liver regeneration and muscle cell proliferation (51–53). However, in both cases, these tissues normally regenerate.
In our studies, p21 down-regulation plays a most striking role as deletion of this molecule alone establishes appendage regenerative competence in whole animals. Thus, using the ear hole closure model, the control WT mouse strain B6129SF2/J does not close ear holes, similar to other nonregenerating mice, although the CDKN1A (p21)−/− mouse strain does close ear holes and displays morphological and histological regenerative responses similar to MRL mice. Interestingly, this same deletion shows another shared characteristic with the MRL mouse, that of a mild to severe manifestation of a lupus-like syndrome (54, 55). This correlation between regenerative potential and autoimmune state could suggest that in clinical autoimmune disease, a corresponding enhanced regenerative potential might be seen in some patients.
Methods
Animals.
Commercially available mice were obtained from Jackson or Taconic Laboratories. Through-and-through ear hole punches were carried out as previously described (3). Please see SI Text for complete details.
Cell Culture, Cell Cycle Analysis, and Comet Assays.
Primary skin dermal cells from ear pinnae were established and cells from early passages were used. These cells were analyzed for cell cycle using either Propidium Iodide (PI) dye (P-4170; Sigma) or Vybrant DyeCycle Orange (V35005; Molecular Probes) by flow cytometry. Comets were prepared using these cells as previously described (56).
IHC.
Primary ear skin dermal cells were grown on glass coverslips and tissue from normal ears and from the small intestine were fixed and embedded. Staining with antibody is as described previously (6).
Western Blot Analysis.
Western blot analysis was carried out for four different antigens (p53, γH2AX, caspase 3, p21, and actin as a control) using three different tissues (cultured dermal cells, ear pinnae, and small intestine).
TUNEL Analysis.
Paraffin-embedded small intestine was analyzed using the DermaTACS In Situ Apoptosis Detection Kit (4829-30-K; Trevigen, Inc.).
Acknowledgments
We would like to thank T. Halazonetis, R. Naviaux, T. Stomato, and L. Matthew Arthur for their thoughts and useful discussions. This work was supported by grants from the Harold G. and Leila Y. Mathers Foundation, the F.M. Kirby Foundation, the W.W. Smith Foundation, and National Institutes of Health Grants from National Institute of General Medical Sciences (GM073226) and the National Cancer Institute Cancer Center Grant (P30 CA10815). A.S. was supported by a grant from National Cancer Institute, National Institutes of Health.
Footnotes
The authors declare no conflict of interest.
This article contains supporting information online at www.pnas.org/cgi/content/full/1000830107/DCSupplemental.
References
Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences
Full text links
Read article at publisher's site: https://doi.org/10.1073/pnas.1000830107
Read article for free, from open access legal sources, via Unpaywall: https://europepmc.org/articles/pmc2851923?pdf=render
Free after 6 months at www.pnas.org
http://www.pnas.org/cgi/content/abstract/107/13/5845
Free after 6 months at www.pnas.org
http://www.pnas.org/cgi/content/full/107/13/5845
Free after 6 months at www.pnas.org
http://www.pnas.org/cgi/reprint/107/13/5845.pdf
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Article citations
Bioinformatics analysis of signature genes related to cell death in keratoconus.
Sci Rep, 14(1):12749, 03 Jun 2024
Cited by: 0 articles | PMID: 38830963 | PMCID: PMC11148072
Absence of E2f1 Negates Pro-osteogenic Impacts of p21 Absence.
Calcif Tissue Int, 114(6):625-637, 21 Apr 2024
Cited by: 0 articles | PMID: 38643416
Epithelial-mesenchymal transition: an organizing principle of mammalian regeneration.
Front Cell Dev Biol, 11:1101480, 26 Oct 2023
Cited by: 2 articles | PMID: 37965571 | PMCID: PMC10641390
The superior healing capacity of MRL tendons is minimally influenced by the systemic environment of the MRL mouse.
Sci Rep, 13(1):17242, 11 Oct 2023
Cited by: 0 articles | PMID: 37821476 | PMCID: PMC10567747
Size-Specific Modulation of a Multienzyme Glucosome Assembly during the Cell Cycle.
ACS Bio Med Chem Au, 3(5):461-470, 08 Aug 2023
Cited by: 3 articles | PMID: 37876499 | PMCID: PMC10591302
Go to all (126) article citations
Other citations
Data
Data behind the article
This data has been text mined from the article, or deposited into data resources.
BioStudies: supplemental material and supporting data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Epimorphic regeneration in mice is p53-independent.
Cell Cycle, 9(18):3667-3673, 21 Sep 2010
Cited by: 16 articles | PMID: 20855943 | PMCID: PMC3047795
Review Free full text in Europe PMC
The role of p21 in regulating mammalian regeneration.
Stem Cell Res Ther, 2(3):30, 29 Jun 2011
Cited by: 13 articles | PMID: 21722344 | PMCID: PMC3152998
Review Free full text in Europe PMC
Cell cycle regulation and regeneration.
Curr Top Microbiol Immunol, 367:253-276, 01 Jan 2013
Cited by: 34 articles | PMID: 23263201
Review
Regeneration of the ear after wounding in different mouse strains is dependent on the severity of wound trauma.
Dev Dyn, 226(2):388-397, 01 Feb 2003
Cited by: 48 articles | PMID: 12557217
Funding
Funders who supported this work.
NCI NIH HHS (2)
Grant ID: P30 CA10815
Grant ID: P30 CA010815
NIGMS NIH HHS (2)
Grant ID: GM073226
Grant ID: R01 GM073226